{"id":29144,"date":"2016-12-16T12:04:41","date_gmt":"2016-12-16T11:04:41","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=29144"},"modified":"2016-12-16T12:04:41","modified_gmt":"2016-12-16T11:04:41","slug":"payback-farmaceutica-ancora-uno-stop-dal-tar","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/payback-farmaceutica-ancora-uno-stop-dal-tar\/","title":{"rendered":"Pharmaceutical payback. One more stop from the Tar"},"content":{"rendered":"<p>Suspended payment of a company relating to 2013-2015. &quot;Aifa will have to file a report&quot;. All postponed to November 2017<\/p>\n<p><em>New stop by the Lazio Regional Administrative Court on pharmaceutical payback. This time, with an order, the administrative judges accepted the suspension of the payment order for the shelf <a href=\"http:\/\/www.quotidianosanita.it\/scienza-e-farmaci\/articolo.php?articolo_id=44292\" target=\"_blank\" rel=\"noopener\">breakthrough of hospital pharmaceutical expenditure for the years 2013\/2014\/2015<\/a> addressed to the company Therabel Gn Pharma Spa of 192 thousand euros.<\/em><\/p>\n<p><span style=\"color: #0000ff;\"><a style=\"color: #0000ff;\" href=\"http:\/\/www.quotidianosanita.it\/allegati\/create_pdf.php?all=5715192.pdf\" target=\"_blank\" rel=\"noopener\"> Tar payback ordinance 2013-2015<\/a><\/span><\/p>\n<p><a href=\"http:\/\/www.quotidianosanita.it\/scienza-e-farmaci\/articolo.php?articolo_id=46125\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #0000ff;\">(...continued in daily health newspaper of 15 December 2196)<\/span><\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Sospeso pagamento di un\u2019azienda relativo al 2013-2015. \u201cAifa dovr\u00e0 depositare relazione\u201d. Tutto rinviato a novembre 2017 Nuovo stop del Tar del Lazio in materia di payback farmaceutico. Questa volta con un\u2019ordinanza i giudici amministrativi hanno accolto la sospensione dell\u2019ordine di pagamento per il ripiano dello sfondamento della spesa farmaceutica ospedaliera per gli anni 2013\/2014\/2015 rivolto &hellip;<\/p>","protected":false},"author":4,"featured_media":21889,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[49,41,26],"class_list":["post-29144","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-aifa","tag-leggisentenze","tag-spesa-farmaceutica"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/29144","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=29144"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/29144\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/21889"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=29144"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=29144"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=29144"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}